NR1I2 and inflammatory bowel disease: While the majority of findings advocate for anti-inflammatory effects of activated PXR (inflammatory bowel disease; M. tuberculosis-infected macrophages), in selected cells or tissues without microbial infection (e.g., endothelial cells), PXR activation can promote pro-inflammatory responses.